Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
R
Richard Adams
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
487
Papers
12.7K
Citations
53
h-index
158
i10-index
Richard Adams is an academic researcher from Cardiff University. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Colorectal and Anal Carcinomas & Gastric Cancer Management and Outcomes. The author has an h-index of 53, co-authored 414 publications.
ORCID: 0000-0003-3915-7243Papers by this author
worksConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Clinical development of new drug–radiotherapy combinations
2016 · Nature Reviews Clinical Oncology · 304 citations
https://doi.org/10.1038/nrclinonc.2016.79
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
2011 · The Lancet Oncology · 262 citations
https://doi.org/10.1016/s1470-2045(11)70102-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat